Immortalized fibroblasts from NF-κB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor α after transformation by v-Ras
- 18 July 2005
- journal article
- Published by Springer Nature in Oncogene
- Vol. 24 (43) , 6574-6583
- https://doi.org/10.1038/sj.onc.1208809
Abstract
Activation of the NF-B pathway can either promote or block apoptosis and oncogenesis in different cell types and circumstances. In this report, we show that independently derived immortalized mouse embryonic fibroblast cell lines prepared from RelA knockout mice have different phenotypes, based on their sensitivity to tumor necrosis factor (TNF)-induced apoptosis, morphology, ability to form colonies in soft agar, and the presence of distinct B site-binding complexes. In addition, these RelA-deficient cell lines appear to have distinct alterations in the p53 pathway, which correlate with the normal vs transformed status of individual cell lines. We have also infected mouse embryonic fibroblasts lacking RelA, c-Rel or p50 with a retrovirus for the expression of v-Ha-Ras to determine whether individual NF-B family members are required for Ras-mediated transformation. All three NF-B-deficient cell types could be transformed by v-Ha-Ras. However, v-Ras-infected RelA-deficient cells formed colonies in soft agar at an approximately fourfold reduced efficiency compared to v-Ras-transformed control mouse 3T3 and p50-deficient cells. Ras transformation did not alter the sensitivity of RelA-deficient cells to TNF-induced apoptosis, and Ras transformation did not affect the general resistance of 3T3, c-Rel-deficient, and p50-deficient cells to TNF-induced apoptosis. However, TNF specifically and dose-dependently decreased the ability of v-Ras-transformed RelA-deficient cells to form colonies in soft agar. These results suggest that RelA is a potential protein target for human tumors driven by oncogenic Ras mutations, but caution that inhibition of RelA may promote tumorigenesis in some circumstances.Keywords
This publication has 47 references indexed in Scilit:
- Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genesOncogene, 2004
- To be, or not to be: NF-κB is the answer – role of Rel/NF-κB in the regulation of apoptosisOncogene, 2003
- Transfection of a dominant-negative mutant NF-kB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells: interaction of IkBm and p53Oncogene, 2003
- Lysyl Oxidase Inhibits Ras-Mediated Transformation by Preventing Activation of NF-κBMolecular and Cellular Biology, 2003
- NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasiaNature, 2003
- β-catenin interacts with and inhibits NF-κB in human colon and breast cancerCancer Cell, 2002
- Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-κB have a malignantly transformed phenotypeOncogene, 2002
- The Non-ankyrin C Terminus of IκBα Physically Interacts with p53 in Vivo and Dissociates in Response to Apoptotic Stress, Hypoxia, DNA Damage, and Transforming Growth Factor-β1-mediated Growth SuppressionJournal of Biological Chemistry, 2002
- Signal-dependent and -independent Degradation of Free and NF-κB-bound IκBαJournal of Biological Chemistry, 2000
- NF-κB is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesisOncogene, 2000